The Hydration Pharmaceuticals Company Limited

Equities

HPC

AU0000187957

Pharmaceuticals

Market Closed - Australian S.E. 09:10:58 2024-05-01 pm EDT 5-day change 1st Jan Change
0.015 AUD +15.38% Intraday chart for The Hydration Pharmaceuticals Company Limited +25.00% -37.50%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
The Hydration Pharmaceuticals' Revenue Falls 14% in March Quarter MT
The Hydration Pharmaceuticals Co. Secures AU$1.7 Million in Funding from Variation of Facility Agreement MT
The Hydration Pharmaceuticals Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
10,387,823 Options of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 14-DEC-2023. CI
17,482,735 Ordinary Shares of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 14-DEC-2023. CI
6,671,720 Ordinary Shares of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 10-DEC-2023. CI
The Hydration Pharmaceuticals Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
The Hydration Pharmaceuticals Company Limited Announces Resignation of Gretta van Riel as Non-Executive Director, Effective September 26, 2023 CI
The Hydration Pharmaceuticals Posts 24% Jump in Q2 Net Sales MT
The Hydration Pharmaceuticals Achieves Daily Retail Sales Milestone on Amazon Canada MT
9,568,677 Ordinary Shares of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 10-JUN-2023. CI
The Hydration Pharmaceuticals Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
The Hydration Pharmaceuticals Sees Record High Sales of $1 Million in January MT
The Hydration Pharmaceuticals Company Limited Announces Unaudited Sales Results for the Month of January 2023 CI
The Hydration Pharmaceuticals Company Limited Announces Executive Changes CI
The Hydration Pharmaceuticals Posts 92% Jump in Annual Retail Sales Through Amazon USA MT
10,835,361 Ordinary Shares of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 10-DEC-2022. CI
2,416,700 Ordinary Shares of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 3-DEC-2022. CI
The Hydration Pharmaceuticals Launches Co-Branded Product; Shares Slip 4% MT
The Hydration Pharmaceuticals Company Limited Launches Co-Branded Product CI
Shay Mitchell Debuts New Lemon Squeeze Flavor Rapid Hydration Drink in Collaboration with HydraLyte CI
Hydration Pharmaceuticals Company Limited Secures Key Regulatory Approval for Product Manufacturing for the Canadian Market CI
The Hydration Pharmaceuticals Draws Down $4.2 Million Under Loan Facility MT
The Hydration Pharmaceuticals Obtains $7.5 Million Loan MT
The Hydration Pharmaceuticals Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chart The Hydration Pharmaceuticals Company Limited
More charts
The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company. The Company is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The Company markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has a sales footprint in various markets, including the United States, Canada, China, and the United Kingdom. Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, and others.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. HPC Stock
  4. News The Hydration Pharmaceuticals Company Limited
  5. The Hydration Pharmaceuticals Co. Secures AU$1.7 Million in Funding from Variation of Facility Agreement